Literature DB >> 8064300

Contraction tension and kinetics of the peroneus longus muscle in golden retriever muscular dystrophy.

J N Kornegay1, N J Sharp, D J Bogan, S D Van Camp, J R Metcalf, R O Schueler.   

Abstract

Contraction tension and kinetics of the peroneus longus muscle were studied in dogs with the Duchenne homologue, golden retriever muscular dystrophy (GRMD), in advance of evaluating localized therapies such as myoblast transplantation. Absolute and both muscle- and body-weight-corrected twitch tension in GRMD dogs were low compared to normal litter mates at 3 months of age (p < 0.0005 for all). Tetanic tension was affected similarly. However, whereas absolute values were still reduced at 6 months (p < 0.0005 for twitch and 0.005 for tetany), twitch and tetanic tension corrected for either muscle or body weight was not statistically different, suggesting that the peroneus longus may be relatively spared in GRMD. Post-tetanic potentiation was more pronounced in GRMD versus normal dogs at both 3 (p < 0.0001) and 6 (p < 0.01) months. The degree of positive staircase at 3 months of age did not differ. Twitch contraction and relaxation times were dramatically prolonged, and there was concomitant sustained electrical activity, at, or before, 6 months of age in some severely affected dogs. Relatively few carriers were evaluated at these ages, but their values were similar to those of normal dogs. Apparent sparing of the peroneus longus muscle may limit application of this technique to evaluation of therapies administered early in life or in combination with toxins. Treatment to alter changes in contraction kinetics could also be assessed.

Entities:  

Mesh:

Year:  1994        PMID: 8064300     DOI: 10.1016/0022-510x(94)90210-0

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  12 in total

1.  Laminin-111 protein therapy enhances muscle regeneration and repair in the GRMD dog model of Duchenne muscular dystrophy.

Authors:  Pamela Barraza-Flores; Tatiana M Fontelonga; Ryan D Wuebbles; Hailey J Hermann; Andreia M Nunes; Joe N Kornegay; Dean J Burkin
Journal:  Hum Mol Genet       Date:  2019-08-15       Impact factor: 6.150

Review 2.  Canine models of Duchenne muscular dystrophy and their use in therapeutic strategies.

Authors:  Joe N Kornegay; Janet R Bogan; Daniel J Bogan; Martin K Childers; Juan Li; Peter Nghiem; David A Detwiler; C Aaron Larsen; Robert W Grange; Ratna K Bhavaraju-Sanka; Sandra Tou; Bruce P Keene; James F Howard; Jiahui Wang; Zheng Fan; Scott J Schatzberg; Martin A Styner; Kevin M Flanigan; Xiao Xiao; Eric P Hoffman
Journal:  Mamm Genome       Date:  2012-01-05       Impact factor: 2.957

Review 3.  The paradox of muscle hypertrophy in muscular dystrophy.

Authors:  Joe N Kornegay; Martin K Childers; Daniel J Bogan; Janet R Bogan; Peter Nghiem; Jiahui Wang; Zheng Fan; James F Howard; Scott J Schatzberg; Jennifer L Dow; Robert W Grange; Martin A Styner; Eric P Hoffman; Kathryn R Wagner
Journal:  Phys Med Rehabil Clin N Am       Date:  2012-02       Impact factor: 1.784

4.  Respiratory dysfunction in unsedated dogs with golden retriever muscular dystrophy.

Authors:  Justin C DeVanna; Joe N Kornegay; Daniel J Bogan; Janet R Bogan; Jennifer L Dow; Eleanor C Hawkins
Journal:  Neuromuscul Disord       Date:  2013-10-24       Impact factor: 4.296

5.  Kinematics of gait in golden retriever muscular dystrophy.

Authors:  Anthony P Marsh; Joel D Eggebeen; Joe N Kornegay; Chad D Markert; Martin K Childers
Journal:  Neuromuscul Disord       Date:  2009-11-22       Impact factor: 4.296

6.  Dystrophin deficiency compromises force production of the extensor carpi ulnaris muscle in the canine model of Duchenne muscular dystrophy.

Authors:  Hsiao T Yang; Jin-Hong Shin; Chady H Hakim; Xiufang Pan; Ronald L Terjung; Dongsheng Duan
Journal:  PLoS One       Date:  2012-09-04       Impact factor: 3.240

7.  Comparative Genomics of X-linked Muscular Dystrophies: The Golden Retriever Model.

Authors:  Candice Brinkmeyer-Langford; Joe N Kornegay
Journal:  Curr Genomics       Date:  2013-08       Impact factor: 2.236

8.  A comparative study of N-glycolylneuraminic acid (Neu5Gc) and cytotoxic T cell (CT) carbohydrate expression in normal and dystrophin-deficient dog and human skeletal muscle.

Authors:  Paul T Martin; Bethannie Golden; Jonathan Okerblom; Marybeth Camboni; Kumaran Chandrasekharan; Rui Xu; Ajit Varki; Kevin M Flanigan; Joe N Kornegay
Journal:  PLoS One       Date:  2014-02-05       Impact factor: 3.240

9.  NBD delivery improves the disease phenotype of the golden retriever model of Duchenne muscular dystrophy.

Authors:  Joe N Kornegay; Jennifer M Peterson; Daniel J Bogan; William Kline; Janet R Bogan; Jennifer L Dow; Zheng Fan; Jiahui Wang; Mihye Ahn; Hongtu Zhu; Martin Styner; Denis C Guttridge
Journal:  Skelet Muscle       Date:  2014-10-23       Impact factor: 4.912

10.  Dystrophin-deficient dogs with reduced myostatin have unequal muscle growth and greater joint contractures.

Authors:  Joe N Kornegay; Daniel J Bogan; Janet R Bogan; Jennifer L Dow; Jiahui Wang; Zheng Fan; Naili Liu; Leigh C Warsing; Robert W Grange; Mihye Ahn; Cynthia J Balog-Alvarez; Steven W Cotten; Monte S Willis; Candice Brinkmeyer-Langford; Hongtu Zhu; Joe Palandra; Carl A Morris; Martin A Styner; Kathryn R Wagner
Journal:  Skelet Muscle       Date:  2016-04-04       Impact factor: 4.912

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.